Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting

Salil V. Deo, Sadeer Al-Kindi, Salim S. Virani, Stephen Fremes

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)723-730.e4
JournalJournal of Thoracic and Cardiovascular Surgery
Issue number2
Publication statusPublished - Feb 2024


  • PSCK9 inhibitor
  • atherosclerosis
  • bempedoic acid
  • coronary artery bypass grafting
  • coronary artery disease
  • ezetimibe
  • inclisiran
  • statin intolerance
  • statin-associated muscle symptoms

Cite this